---
layout: post
title: ZebraMedical Harvard Business Review Case
date: 2024-01-27 11:46:00
description:
tags:
categories:
thumbnail: assets/img/9.jpg
images:
  compare: true
  slider: true
---

Case Analysis for ZebraMedical. Navigating the probable challenges for the companyâ€™s AI after being granted the FDA approval. How it can emerge victorious and capitalize on the opportunities.

<swiper-container keyboard="true" navigation="true" pagination="true" pagination-clickable="true" pagination-dynamic-bullets="true" rewind="true">
  <swiper-slide>{% include figure.liquid loading="eager" path="assets/img/9.jpg" class="img-fluid rounded z-depth-1" %}</swiper-slide>
  <swiper-slide>{% include figure.liquid loading="eager" path="assets/img/7.jpg" class="img-fluid rounded z-depth-1" %}</swiper-slide>
  <swiper-slide>{% include figure.liquid loading="eager" path="assets/img/8.jpg" class="img-fluid rounded z-depth-1" %}</swiper-slide>
  <swiper-slide>{% include figure.liquid loading="eager" path="assets/img/10.jpg" class="img-fluid rounded z-depth-1" %}</swiper-slide>
  <swiper-slide>{% include figure.liquid loading="eager" path="assets/img/12.jpg" class="img-fluid rounded z-depth-1" %}</swiper-slide>
</swiper-container>
